For effective use in detecting specific types of cancer, tumor-targeting nanoparticles must evade the immune system, remain intact for a clinically relevant time frame, and
Rebeca Romero Aburto PhD is an Imagion Biosystems research collaborator and a post-doctoral fellow at the University of Texas MD Anderson Cancer Center. As an
We have temporarily suspended our nanoparticle operations. Please revisit us in the future. We apologize for the inconvenience. Any questions, please email: info@imagionbio.com Dismiss